The genomic landscape of male breast cancers
Purpose: Male breast cancer is rare, and its genomic landscape has yet to be fully
characterized. Lacking studies in men, treatment of males with breast cancer is extrapolated …
characterized. Lacking studies in men, treatment of males with breast cancer is extrapolated …
Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis
EC Fields, P DeWitt, CM Fisher… - International Journal of …, 2013 - Elsevier
Purpose To analyze the stage-specific management of male breast cancer (MBC) with
surgery and radiation therapy (RT) and relate them to outcomes and to female breast cancer …
surgery and radiation therapy (RT) and relate them to outcomes and to female breast cancer …
Male breast cancer: from molecular genetics to clinical management
M Pensabene, C Von Arx, M De Laurentiis - Cancers, 2022 - mdpi.com
Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …
[HTML][HTML] Male breast cancer: a review
IS Fentiman - Ecancermedicalscience, 2009 - ncbi.nlm.nih.gov
Male breast cancer (MBC) is rare, with the peak age of onset at 71 years. BRCA2 mutations
are more frequent than BRCA1 with 20% of cases giving a family history. Risk factors for …
are more frequent than BRCA1 with 20% of cases giving a family history. Risk factors for …